FMC
37
7
GT
37
4
VIX
66
3
NWS
62
2
PEG
57
4
CLX
68
3
STX
39
4
COF
49
5
UNP
48
5
EFX
43
5
R
60
5
LEN
19
5
PHM
49
9
CAH
50
2
BEN
28
3
CB
50
2
EMC
33
6
DVA
71
5
APA
42
3
MCK
56
4
FMC
37
7
GT
37
4
VIX
66
3
NWS
62
2
PEG
57
4
CLX
68
3
STX
39
4
COF
49
5
UNP
48
5
EFX
43
5
R
60
5
LEN
19
5
PHM
49
9
CAH
50
2
BEN
28
3
CB
50
2
EMC
33
6
DVA
71
5
APA
42
3
MCK
56
4
Financhill
Back

Smith-Midland Vs. Biomarin Pharmaceutical Industry Stock Comparison

Sell
50

SMID
Smith-Midland

Last Price:
$38.80
Seasonality Move:
2.52%
Buy
54

BMRN
Biomarin Pharmaceutical

Last Price:
$63.83
Seasonality Move:
2.97%
Sell
50
Smith-Midland (SMID) is a Sell

Is Smith-Midland a Buy, Sell or Hold?

  • The current Smith-Midland [SMID] share price is $39.43. The Score for SMID is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
  • SMID is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
54
Biomarin Pharmaceutical (BMRN) is a Buy

Is Biomarin Pharmaceutical a Buy, Sell or Hold?

  • The current Biomarin Pharmaceutical [BMRN] share price is $63.81. The Score for BMRN is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
  • BMRN is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

SMID Stock Price Chart

What is Smith-Midland's stock price today?

  • The Smith-Midland share price today is $39.43
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SMID is experiencing buying pressure, which is a positive indicator for future bullish movement.

BMRN Stock Price Chart

What is Biomarin Pharmaceutical's stock price today?

  • The Biomarin Pharmaceutical share price today is $63.81
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BMRN is experiencing selling pressure, which indicates risk of future bearish movement.

SMID Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.26 Sell
Relative Strength Index (14 RSI): 37.98 Sell
Chaikin Money Flow: 18596 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (41.31 - 47.69) Sell
Bollinger Bands (100): (32.33 - 44.19) Buy

BMRN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.09 Buy
Relative Strength Index (14 RSI): 38.38 Sell
Chaikin Money Flow: -1568648 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (65.38 - 67.36) Sell
Bollinger Bands (100): (62.66 - 79.7) Sell

SMID Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 41.09 Sell
20-day SMA: 43.48 Sell
50-day SMA: 42.97 Sell
200-day SMA: 36.42 Buy
8-day EMA: 40.76 Sell
20-day EMA: 42.66 Sell
50-day EMA: 42.08 Sell
200-day EMA: 37.03 Buy

BMRN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 66.86 Sell
20-day SMA: 66.35 Sell
50-day SMA: 65.77 Sell
200-day SMA: 77.61 Sell
8-day EMA: 66.41 Sell
20-day EMA: 66.39 Sell
50-day EMA: 67.19 Sell
200-day EMA: 75.66 Sell

Smith-Midland Earnings Growth & SMID Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Biomarin Pharmaceutical Earnings Growth & BMRN Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.27 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.88 per share, and an increase next year of $1.02 per share.

Smith-Midland Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Biomarin Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):